glp-1 wonder Are agonists like Ozempic the next drugs? GLP-1 Drugs: 6 Things We've
Description
In September 2025, researchers at UCLA published a study in ACR Open Rheumatology (Kellner and colleagues)
TRIPLE GLUCAGON-LIKE PEPTIDE-1/GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE/GLUCAGON RECEPTOR TRIAGONISTS Undoubtedly, the approval of the first GLP-1 receptor agonist in 2005 has revolutionised the pharmacological treatment of obesity and T2DM
BMJ 341:c2701 Manfield JH et al (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension
A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe
They work by mimicking a natural hormone that helps control appetite and blood sugar
